Status Approved
First Submitted Date
2021/03/23
Registered Date
2021/03/30
Last Updated Date
2023/02/21
CRIS Required
WHO ICTRP (International Clinical Trial Registry Platform) Required
1. Background
CRIS Registration Number |
KCT0006042 |
---|---|
Unique Protocol ID | NCv1.2 |
Public/Brief Title | Comparison of Cataract Surgery with Illuminator Chopper and Surgical microscope light source |
Scientific Title | Prospective Randomized, Paired-Eye, Controlled Study on Comparison of Intraoperative Patient Experience and Postoperative Clinical Outcomes after Phacoemulsification Cataract Surgery with Illuminator Chopper and Conventional Chopper with Surgical microscope light source |
Acronym | Illuminator chopper |
MFDS Regulated Study | No |
IND/IDE Protocol | No |
Registered at Other Registry | No |
Healthcare Benefit Approval Status | Not applicable |
2. Institutional Review Board / Ethics Committee
Board Approval Status | Submitted approval |
---|---|
Board Approval Number | 2021AS0063 |
Approval Date | 2021-03-09 |
Institutional Review Board Name | Korea University Ansan Hospital Institutional Review Board |
Institutional Review Board Address | 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do |
Institutional Review Board Telephone | 031-412-6514 |
Data Monitoring Committee | No |
3. Contact Details
Contact Person for Principal Investigator / Scientific Queries | |
---|---|
Name | Dongheun Nam |
Title | Professor |
Telephone | +82-32-460-3364 |
Affiliation | Gachon University Gil Medical Center |
Address | 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do |
Contact Person for Public Queries | |
Name | Hee Young Kim |
Title | Clinical research co |
Telephone | +82-31-412-5168 |
Affiliation | Korea University Ansan Hospital |
Address | 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do |
Contact Person for Updating Information | |
Name | Young Sub Eom |
Title | Professor |
Telephone | +82-31-412-5168 |
Affiliation | Korea University Ansan Hospital |
Address | 123, Jeokgeum-ro, Danwon-gu, Ansan-si, Gyeonggi-do |
4. Status
Study Site | Multi-center Number of center : 4 | |
---|---|---|
Overall Recruitment Status | Completed | |
Date of First Enrollment | 2021-03-23 Actual | |
Target Number of Participant | 90 | |
Primary Completion Date | 2022-11-24 , Actual | |
Study Completion Date | 2022-11-24 , Actual | |
Recruitment Status by Participating Study Site 1 | ||
Name of Study | Korea University Ansan Hospital | |
Recruitment Status | Completed | |
Date of First Enrollment | 2021-06-09 , | |
Recruitment Status by Participating Study Site 2 | ||
Name of Study | Gachon University Gil Medical Center | |
Recruitment Status | Completed | |
Date of First Enrollment | 2021-03-23 , | |
Recruitment Status by Participating Study Site 3 | ||
Name of Study | Inje University Ilsan Paik Hospital | |
Recruitment Status | Completed | |
Date of First Enrollment | 2021-10-12 , | |
Recruitment Status by Participating Study Site 4 | ||
Name of Study | Soon Chun Hyang University Hospital Seoul | |
Recruitment Status | Completed | |
Date of First Enrollment | 2021-09-16 , |
5. Source of Monetary / Material Support
1. Source of Monetary/Material Support | |
---|---|
Organization Name | Korea Drug Development Fund |
Organization Type | Government |
Project ID | HI20C2151 |
6. Sponsor Organization
1. Sponsor Organization | |
---|---|
Organization Name | Korea University Ansan Hospital |
Organization Type | Medical Institute |
7. Study Summary
Lay Summary | The purpose of this clinical study is investigate whether there is a difference in discomfort and the clinical outcomes after cataract surgery between performing cataract surgery under a surgical microscope light source traditionally used and performing cataract surgery using an illuminator chaper light source developed by Oculight. |
---|
8. Study Design
Study Type | Interventional Study |
---|---|
Study Purpose | Treatment |
Phase | Not applicable |
Intervention Model | Factorial |
Blinding/Masking | Single |
Blinded Subject | Subject |
Allocation | RCT |
Intervention Type | Medical Device |
Intervention Description | The order of selection of surgical methods will be randomly assigned to patients who have listened to the explanation of the clinical trial and voluntarily agreed to participate. The Excel program is used to generate random numbers 1 or 2, and in case of 1, the right eye is operated using an illuminat or chopper for cataract surgery and the left eye is operated under surgical microscope light source with conventional chopper. 1. Cataract surgery on the right with an illuminator chopper, and surgery on the left eye under microscope light source. 2. Cataract surgery on the right under microscope light source, and surgery on the left eye with an illuminator chopper. |
Number of Arms | 2 |
Arm 1 |
Arm Label Right eye with illuminator chopper |
Target Number of Participant 45 |
|
Arm Type Experimental |
|
Arm Description Cataract surgery on the right with an illuminator chopper, and surgery on the left eye under microscope light source |
|
Arm 2 |
Arm Label Left eye with illuminator chopper |
Target Number of Participant 45 |
|
Arm Type Experimental |
|
Arm Description Cataract surgery on the right under microscope light source, and surgery on the left eye with an illuminator chopper |
9. Subject Eligibility
Condition(s)/Problem(s) |
* (H00-H59)Diseases of the eye and adnexa (H26.99)Cataract, unspecified, unspecified side Cataract |
---|---|
Rare Disease | No |
Inclusion Criteria |
Gender Both |
Age 20Year~No Limit |
|
Description 1. Over 20 years old 2. patients diagnosed with binocular cataract 3. when both eyes are suitable for cataract surgery 4. if the best corrected visual acuity is expected to be 0.5 Snellen or higher after cataract surgery 5. patients for whom no other secondary surgery was planned during the study period 6. patients who can comply with the examination procedure during the entire study period 7. patients who provide written consent. |
|
Exclusion Criteria |
1. in the case of eye diseases other than cataracts that may cause complications or affect clinical outcomes (e.g., anterior segment pathology, corneal dystrophy, ocular inflammation, retinal disorders, or neurological disorders) 2. in case of preoperative ocular or systemic conditions and drug use that may affect the research results or cause excessive risk to the study subject, or complications may occur 3. congenital eye abnormalities 4. if subjects have a history of ophthalmic surgery that may affect the study results or pose a risk to the patient 5. when prior consent cannot be obtained. |
Healthy Volunteers | No |
10. Outcome Measure(s)
Type of Primary Outcome | Efficacy | |
---|---|---|
Primary Outcome(s) 1 | ||
Outcome | Patient experience score during surgery |
|
Timepoint | Immediately after surgery |
|
Secondary Outcome(s) 1 | ||
Outcome | Capsulorrhexis area |
|
Timepoint | 6 months after surgery |
|
Secondary Outcome(s) 2 | ||
Outcome | Anterior capsule opacity score |
|
Timepoint | 6 months after surgery |
|
Secondary Outcome(s) 3 | ||
Outcome | Posterior capsule opacity score |
|
Timepoint | 6 months after surgery |
|
Secondary Outcome(s) 4 | ||
Outcome | Score for evaluating the degree of cooperation of the patient during surgery |
|
Timepoint | Immediately after surgery |
|
Secondary Outcome(s) 5 | ||
Outcome | Operation time and ultrasound use time |
|
Timepoint | Immediately after surgery |
|
Secondary Outcome(s) 6 | ||
Outcome | Visual acuity |
|
Timepoint | 1 week, 1 month, 3, and 6 months after surgery |
|
Secondary Outcome(s) 7 | ||
Outcome | Corneal thickness |
|
Timepoint | 1 week, 1 month, 3, and 6 months after surgery |
|
Secondary Outcome(s) 8 | ||
Outcome | Macular thickness |
|
Timepoint | 1 week, 1 month, 3, and 6 months after surgery |
11. Study Results and Publication
Result Registered | No |
---|
12. Sharing of Study Data(Deidentified Individual-Patient Data, IPD)
Sharing Statement | No |
---|
TOP
BOTTOM
화면 최하단으로 이동